Titan Pharmaceuticals, Inc.

Navigate Titan Pharmaceuticals, Inc.

  • Home
  • About
    • Overview
    • Management Team
    • Board of Directors
    • Careers
  • News
    • Overview
    • Press Releases
    • Events
    • Presentations
    • In the News
    • Media Resources
  • Investors
    • Overview
    • News / Events
    • Company Information
    • Stock Data
    • SEC Filings
    • Corporate Governance
  • Contact
  • Search
  • Twitter

Press Releases

  • Home
  • News
  • Press Releases
News

Navigate News

  • Overview
  • Press Releases
  • Events
  • Presentations
  • In the News
  • Media Resources

Press Releases

  • All News
  • 2025
  • 2024
  • 2023
  • 2022
  • 2021
  • 2020
  • 2019
  • 2018
  • 2017
  • 2016
  • 2015
  • 2014
  • 2013
  • 2012
  • 2011
  • 2010
  • 2009

Titan Pharmaceuticals Presents Phase 3 Probuphine™ Data at Society for Neuroscience Annual Meeting

November 17, 2010

Titan Pharmaceuticals Announces Third Quarter 2010 Financial Results

November 15, 2010

Titan Reports Third Quarter 2010 Fanapt® Royalty

October 25, 2010

Titan Pharmaceuticals Announces Journal of the American Medical Association Publication of Phase 3 Probuphine™ Data

October 12, 2010

Titan Pharmaceuticals Completes $5 Million Loan

September 28, 2010

Titan Reports Completion of Patient Enrollment in Phase 3 Study of Probuphine™

September 22, 2010

Titan Pharmaceuticals Announces Second Quarter 2010 Financial Results

August 16, 2010

Titan Reports Patient Enrollment in Phase III Study of Probuphine® is Ahead of Schedule

August 3, 2010

Titan Receives SBIR Grant to Investigate Long Term Treatment for Parkinson's Disease

July 26, 2010

Titan Reports Second Quarter 2010 Fanapt® Royalty

July 23, 2010

  • 1
  • 2
  • Next »
© 2025 Titan Pharmaceuticals, Inc. All Rights Reserved.
Privacy Policy Titan FCOI Policy Disclaimer Sitemap Twitter